Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
This protects against gallbladder complications, which occur in roughly 1.4 percent of cases during rapid weight loss
The SYNCHRONIZE-MASLD phase 3, randomized, double-blind, placebo-controlled trial included 216 adults (131 female and 85 male) with obesity (defined as a body mass index 30 kg m 2 or 27 kg m 2 with at least one obesity complication) and at-risk metabolic dysfunction-associated steatotic liver disease (MASLD), defined by MASLD with evidence of liver inflammation and/or fibrosis by noninvasive tests (NITs) or biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH)
Diabetes Obes Metab (2022) 24(1):14853
Important Note Do not combine prescription treatments without provider guidance
Steroids (1988) 52(56):583608
US$ 28.08
US$ 22.55
US$ 22.75
US$ 28.26
US$ 23.43
